SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Shorts
XOMA 32.98-0.7%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: (no name provided) who wrote (56)8/2/1998 1:49:00 AM
From: chester lee  Read Replies (1) of 61
 
Kafka666,

DO you have any insight to INCL. They are a biotech stock that recently popped from 2 bits to $5-1/2 yesterday. Insiders were selling as recent as June for $2.75 per stub.

July 15, 1998, Incontrol Inc. announced an June '98 three-month loss per share, $0.36 vs loss of $0.45 for same period a year ago, and six-month loss of $0.84 vs loss of $0.88 for same period a year ago.

Net losses of $6,305,000 for three-month and $15,414,000 for six-months of 1998 include an $1,400,000 restructuring charge and an net credit of $3,933,000 from stock options.

Not much chance of a squeeze, w/ 19mm shares outstanding and short interest at less than one day to cover. swarm.glamus.de

The fundamentals suggest to me this is a short, but without the clear pump and dump evidence, I can't understand what's driving up this stock. Do they have potential blockbuster products in teh pipeline. Is their intellectual property worth more than their current market cap of $106mm.

Your thoughts are appreciated.

Chester
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext